We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Patients Taking Lower Maintenance Doses of Peanut Oral Immunotherapy May Still Achieve Desensitization

News   Mar 05, 2018 | Original Story from American Academy of Allergy, Asthma & Immunology.

 
Patients Taking Lower Maintenance Doses of Peanut Oral Immunotherapy  May Still Achieve Desensitization
 
 
 

RELATED ARTICLES

Immune Cell Acts as Shuttle To Spread HIV Around the Body

News

Research in mice suggests that particular immune cells act as a type of “shuttle” for facilitating the spread of HIV-1 virus-like particles.

READ MORE

Exploring the Synthetic Biology Revolution

News

Cell-free engineering has evolved from a specialized research tool to the backbone of a variety of applications in synthetic biology that stand to dramatically impact society, from the environment to medicine to education.

READ MORE

Key to Keeping Beer Fresher for Longer

News

Scientists have engineered lager yeast to make more molecules that protect beer against staling, resulting in improved flavor stability.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE